Leukemia, a type of cancer found in your blood and bone marrow, is caused by the rapid production of abnormal white blood cells. The high number of abnormal white blood cells are not able to fight infection, and they impair the ability of the …

The ASH Meeting on Hematologic Malignancies features the top experts in the field, comprehensive clinical content in each of the core hematologic malignancies, and opportunities to interact with colleagues in an intimate, small-group setting with no competing sessions.

2024年12月4日 · Dartmouth Cancer Center (DCC) invites applications and nominations for the position of Section Chief, Hematology and Hematologic Malignancy. Founded in 1972 as the Norris Cotton Cancer Center and recently renamed as part of a 2022 rebranding, DCC is one of just 57 NCI-Designated Comprehensive Cancer Centers in the country.

Genomics is central to the diagnosis, risk stratification and prognosis, disease monitoring, and therapeutic decision-making in hematologic malignancies. Clinicians managing patients with hematologic malignancies are faced with making decisions about which tests to order and when, interpreting test results, and which therapies to select ...

Understanding of basic immunology is essential to unlock the underpinnings of hematologic disease. Likewise, immunotherapy has revolutionized treatment for patients and is rapidly being applied to non-malignant disease to improve outcomes.

2023年3月30日 · A new study published in Blood Advances demonstrates that some effective cancer treatments do improve quality of life, revealing that patients with blood cancers experienced a significant improvement in their reported …

Basic, translational, and developmental studies of cellular immunotherapies incorporating T cells, NK cells, regulatory cells, dendritic cells, and other cell populations designed to treat malignancies or other hematologic diseases.

Imaging tests show whether the lymphoma has spread to other parts of your body, like the spleen and lungs. Decisions about treatment are then determined by your doctor, who will consider your age, general health, and stage and type of lymphoma. Hodgkin lymphoma is one of the most curable types of cancer. Treatment options include the following:

Myeloma is cancer of the plasma cells. Plasma cells are white blood cells that produce disease- and infection-fighting antibodies in your body. Myeloma cells prevent the normal production of antibodies, leaving your body's immune system weakened and susceptible to infection.

The ASH Meeting on Hematologic Malignancies features the top experts in the field, comprehensive clinical content, and the opportunity to interact with colleagues. The 2022 meeting webcasts are an opportunity to hear experts present cutting-edge scientific data, out-of-the-box treatment approaches, and challenging patient care cases during ...